News

TAF is a novel, targeted prodrug of tenofovir that has demonstrated high antiviral efficacy similar to Gilead’s Viread® 245 mg of tenofovir disoproxil (as fumarate) (TDF) at one-tenth

Growing evidence has suggested high levels of intense exercise may actually damage your heart causing permanent structural changes resulting in an abnormal heart rhythm. A review published in

Precision BioSciences’ ARCUS genome editing technology will be used to develop an allogeneic chimeric antigen receptor (CAR T) cell therapeutic pipeline directed towards areas of major unmet need

Last December, AstraZeneca agreed to acquire a 55% stake in privately-owned biotech firm Acerta Pharma for $4bn. Acalabrutinib has been recommended as an orphan product for chronic lymphocytic

California-based Vantage Oncology offers radiation oncology, medical oncology and other cancer care services. It will add over 50 cancer centers across 13 US states to McKesson’s business. Biologics

"Receiving orphan drug status in the EU is another encouraging step in the development of RE-024 for the treatment of PKAN," said Alvin Shih, M.D., executive vice president

This filing will add important new clinical data to the current label from two Phase 3 trials evaluating the safety and efficacy of AVYCAZ, in combination with metronidazole,

Results were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Data from the study support the advancement of cabotegravir, an integrase strand transfer inhibitor,

The latest round of funding brings Rani Therapeutics’ total investment to over $70m. Other investors in the round were Virtus Inspire Ventures and Ping An Ventures. The company’s